• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体表达 CD47 实现 CD47 分子交叉配体结合,从而抑制吞噬作用而不传递细胞死亡信号。

CD47 cross-dressing by extracellular vesicles expressing CD47 inhibits phagocytosis without transmitting cell death signals.

机构信息

Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital, and Institute of Immunology, Jilin University, Changchun, China.

Columbia Center for Translational Immunology, Columbia University Medical Center, New York, United States.

出版信息

Elife. 2022 Dec 1;11:e73677. doi: 10.7554/eLife.73677.

DOI:10.7554/eLife.73677
PMID:36454036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9714967/
Abstract

Transgenic CD47 overexpression is an encouraging approach to ameliorating xenograft rejection and alloresponses to pluripotent stem cells, and the efficacy correlates with the level of CD47 expression. However, CD47, upon ligation, also transmits signals leading to cell dysfunction or death, raising a concern that overexpressing CD47 could be harmful. Here, we unveiled an alternative source of cell surface CD47. We showed that extracellular vesicles, including exosomes, released from normal or tumor cells overexpressing CD47 (transgenic or native) can induce efficient CD47 cross-dressing on pig or human cells. Like the autogenous CD47, CD47 cross-dressed on cell surfaces is capable of interacting with SIRPα to inhibit phagocytosis. However, ligation of the autogenous, but not cross-dressed, CD47 induced cell death. Thus, CD47 cross-dressing provides an alternative source of cell surface CD47 that may elicit its anti-phagocytic function without transmitting harmful signals to the cells. CD47 cross-dressing also suggests a previously unidentified mechanism for tumor-induced immunosuppression. Our findings should help to further optimize the CD47 transgenic approach that may improve outcomes by minimizing the harmful effects of CD47 overexpression.

摘要

转染 CD47 过表达是一种有前途的方法,可以改善异种移植物排斥和多能干细胞同种反应,其疗效与 CD47 表达水平相关。然而,CD47 一旦被连接,也会传递导致细胞功能障碍或死亡的信号,这让人担心过表达 CD47 可能有害。在这里,我们揭示了细胞表面 CD47 的另一种来源。我们表明,来自过表达 CD47(转基因或天然)的正常或肿瘤细胞释放的细胞外囊泡,包括外泌体,可以诱导猪或人细胞上有效的 CD47 交叉染色。与自体 CD47 一样,表面交叉染色的 CD47 能够与 SIRPα 相互作用以抑制吞噬作用。然而,自体 CD47 的连接,但不是交叉染色的 CD47,诱导细胞死亡。因此,CD47 交叉染色提供了细胞表面 CD47 的另一种来源,它可以在不向细胞传递有害信号的情况下发挥其抗吞噬作用。CD47 交叉染色还提示了一种以前未被识别的肿瘤诱导免疫抑制机制。我们的发现应该有助于进一步优化 CD47 转基因方法,通过最小化 CD47 过表达的有害影响来提高疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/07e39d1ea21f/elife-73677-sa2-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/3ff511a35ec3/elife-73677-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/3f75bee4c4af/elife-73677-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/79df45e3f147/elife-73677-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/fdeb590f5838/elife-73677-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/36daf0d9aab9/elife-73677-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/c24cba19262f/elife-73677-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/1776c03a2c18/elife-73677-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/28b14657139c/elife-73677-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/0010d90b7171/elife-73677-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/759a4d5eeecf/elife-73677-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/06f2e9b704e9/elife-73677-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/bc1dbc907f6c/elife-73677-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/5ca9e24f37b8/elife-73677-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/61432712e88f/elife-73677-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/f368331e28ac/elife-73677-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/3cfcde415154/elife-73677-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/b7097cac6b15/elife-73677-sa2-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/d16b133548b0/elife-73677-sa2-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/5e224c42d67b/elife-73677-sa2-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/05126ab5c17d/elife-73677-sa2-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/e52e65913e77/elife-73677-sa2-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/07e39d1ea21f/elife-73677-sa2-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/3ff511a35ec3/elife-73677-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/3f75bee4c4af/elife-73677-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/79df45e3f147/elife-73677-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/fdeb590f5838/elife-73677-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/36daf0d9aab9/elife-73677-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/c24cba19262f/elife-73677-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/1776c03a2c18/elife-73677-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/28b14657139c/elife-73677-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/0010d90b7171/elife-73677-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/759a4d5eeecf/elife-73677-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/06f2e9b704e9/elife-73677-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/bc1dbc907f6c/elife-73677-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/5ca9e24f37b8/elife-73677-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/61432712e88f/elife-73677-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/f368331e28ac/elife-73677-fig5-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/3cfcde415154/elife-73677-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/b7097cac6b15/elife-73677-sa2-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/d16b133548b0/elife-73677-sa2-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/5e224c42d67b/elife-73677-sa2-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/05126ab5c17d/elife-73677-sa2-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/e52e65913e77/elife-73677-sa2-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b466/9714967/07e39d1ea21f/elife-73677-sa2-fig7.jpg

相似文献

1
CD47 cross-dressing by extracellular vesicles expressing CD47 inhibits phagocytosis without transmitting cell death signals.外泌体表达 CD47 实现 CD47 分子交叉配体结合,从而抑制吞噬作用而不传递细胞死亡信号。
Elife. 2022 Dec 1;11:e73677. doi: 10.7554/eLife.73677.
2
Expression of a mutant CD47 protects against phagocytosis without inducing cell death or inhibiting angiogenesis.表达突变型 CD47 可防止吞噬作用而不诱导细胞死亡或抑制血管生成。
Cell Rep Med. 2024 Mar 19;5(3):101450. doi: 10.1016/j.xcrm.2024.101450.
3
Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPα capable of binding to human CD47.人 CD47 的表达可使表达能够与人类 CD47 结合的 SIRPα 的免疫缺陷型小鼠中的猪细胞存活。
Cell Transplant. 2011;20(11-12):1915-20. doi: 10.3727/096368911X566253. Epub 2011 Apr 29.
4
Prolonged Survival of Pig Skin on Baboons After Administration of Pig Cells Expressing Human CD47.给予表达人CD47的猪细胞后猪皮肤在狒狒身上的长期存活
Transplantation. 2017 Feb;101(2):316-321. doi: 10.1097/TP.0000000000001267.
5
Transgenic expression of human CD47 reduces phagocytosis of porcine endothelial cells and podocytes by baboon and human macrophages.人CD47的转基因表达可减少狒狒和人巨噬细胞对猪内皮细胞和足细胞的吞噬作用。
Xenotransplantation. 2020 Jan;27(1):e12549. doi: 10.1111/xen.12549. Epub 2019 Sep 8.
6
Attenuation of phagocytosis of xenogeneic cells by manipulating CD47.通过调控CD47减弱异种细胞的吞噬作用
Blood. 2007 Jan 15;109(2):836-42. doi: 10.1182/blood-2006-04-019794. Epub 2006 Sep 28.
7
Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis.外泌体-SIRPα,阻断 CD47 可增强癌细胞吞噬作用。
Biomaterials. 2017 Mar;121:121-129. doi: 10.1016/j.biomaterials.2017.01.004. Epub 2017 Jan 3.
8
Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy.细胞外囊泡在抑制 CD47 信号以用于癌症免疫治疗方面的优势。
J Control Release. 2022 Nov;351:727-738. doi: 10.1016/j.jconrel.2022.09.042. Epub 2022 Oct 7.
9
"Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.作为信号调节蛋白α(SIRPα)拮抗剂的高亲和力CD47胞外域的“维可牢”工程,可增强抗体依赖性细胞吞噬作用。
J Biol Chem. 2015 May 15;290(20):12650-63. doi: 10.1074/jbc.M115.648220. Epub 2015 Apr 2.
10
3'UTR enhances hCD47 cell surface expression, self-signal function, and reduces ER stress in porcine fibroblasts.3'UTR 增强了 hCD47 在猪成纤维细胞表面的表达、自我信号功能,并减轻内质网应激。
Xenotransplantation. 2021 Jan;28(1):e12641. doi: 10.1111/xen.12641. Epub 2020 Sep 6.

引用本文的文献

1
T Cell Activation Induces Synthesis of CD47 Proteoglycan Isoforms and Their Release in Extracellular Vesicles.T细胞活化诱导CD47蛋白聚糖异构体的合成及其在细胞外囊泡中的释放。
Int J Mol Sci. 2025 Aug 28;26(17):8377. doi: 10.3390/ijms26178377.
2
Non-Coding RNAs in Asthma: Regulators of Eosinophil Biology and Airway Inflammation.哮喘中的非编码RNA:嗜酸性粒细胞生物学和气道炎症的调节因子
Diagnostics (Basel). 2025 Jul 10;15(14):1750. doi: 10.3390/diagnostics15141750.
3
Neoantigen enriched biomimetic nanovaccine for personalized cancer immunotherapy.

本文引用的文献

1
Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig-to-baboon xenotransplantation.人CD47在猪肾小球中的表达可预防蛋白尿,并延长猪到狒狒异种移植后的移植物存活时间。
Xenotransplantation. 2021 Nov;28(6):e12708. doi: 10.1111/xen.12708. Epub 2021 Aug 21.
2
Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9 T cells.肿瘤内递送 CCL25 通过募集 CCR9 T 细胞增强三阴性乳腺癌的免疫治疗。
Sci Adv. 2020 Jan 29;6(5):eaax4690. doi: 10.1126/sciadv.aax4690. eCollection 2020 Jan.
3
Vaccination with CD47 deficient tumor cells elicits an antitumor immune response in mice.
用于个性化癌症免疫治疗的新抗原富集仿生纳米疫苗。
Nat Commun. 2025 May 23;16(1):4783. doi: 10.1038/s41467-025-59977-8.
4
Blebbisomes are large, organelle-rich extracellular vesicles with cell-like properties.肌动蛋白小体是具有细胞样特性的、富含细胞器的大型细胞外囊泡。
Nat Cell Biol. 2025 Mar;27(3):438-448. doi: 10.1038/s41556-025-01621-0. Epub 2025 Feb 21.
5
Extracellular Vesicles as Tools for Crossing the Blood-Brain Barrier to Treat Lysosomal Storage Diseases.细胞外囊泡作为穿越血脑屏障治疗溶酶体贮积病的工具
Life (Basel). 2025 Jan 9;15(1):70. doi: 10.3390/life15010070.
6
The biology and function of extracellular vesicles in immune response and immunity.细胞外囊泡在免疫应答和免疫中的生物学和功能。
Immunity. 2024 Aug 13;57(8):1752-1768. doi: 10.1016/j.immuni.2024.07.009.
7
Large-Scale Isolation of Milk Exosomes for Skincare.用于护肤品的大规模牛奶外泌体分离
Pharmaceutics. 2024 Jul 11;16(7):930. doi: 10.3390/pharmaceutics16070930.
8
Extracellular Vesicles from Highly Metastatic Osteosarcoma Cells Induce Pro-Tumorigenic Macrophage Phenotypes.高转移性骨肉瘤细胞来源的细胞外囊泡诱导促肿瘤发生的巨噬细胞表型。
Adv Biol (Weinh). 2024 Jun;8(6):e2300577. doi: 10.1002/adbi.202300577. Epub 2024 Apr 10.
9
Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities.工程化外泌体重塑乳腺癌免疫微环境:分子见解与治疗机会。
Clin Transl Med. 2024 Apr;14(4):e1645. doi: 10.1002/ctm2.1645.
10
Expression of a mutant CD47 protects against phagocytosis without inducing cell death or inhibiting angiogenesis.表达突变型 CD47 可防止吞噬作用而不诱导细胞死亡或抑制血管生成。
Cell Rep Med. 2024 Mar 19;5(3):101450. doi: 10.1016/j.xcrm.2024.101450.
用缺乏 CD47 的肿瘤细胞进行免疫接种可在小鼠中引发抗肿瘤免疫反应。
Nat Commun. 2020 Jan 29;11(1):581. doi: 10.1038/s41467-019-14102-4.
4
Intra-bone bone marrow transplantation from hCD47 transgenic pigs to baboons prolongs chimerism to >60 days and promotes increased porcine lung transplant survival.从hCD47转基因猪到狒狒的骨内骨髓移植可使嵌合状态延长至>60天,并提高猪肺移植的存活率。
Xenotransplantation. 2020 Jan;27(1):e12552. doi: 10.1111/xen.12552. Epub 2019 Sep 23.
5
Transgenic expression of human CD47 reduces phagocytosis of porcine endothelial cells and podocytes by baboon and human macrophages.人CD47的转基因表达可减少狒狒和人巨噬细胞对猪内皮细胞和足细胞的吞噬作用。
Xenotransplantation. 2020 Jan;27(1):e12549. doi: 10.1111/xen.12549. Epub 2019 Sep 8.
6
Extracellular vesicles: a new communication paradigm?细胞外囊泡:一种新的通讯模式?
Nat Rev Mol Cell Biol. 2019 Sep;20(9):509-510. doi: 10.1038/s41580-019-0158-7.
7
Generation of hypoimmunogenic human pluripotent stem cells.生成低免疫原性的人类多能干细胞。
Proc Natl Acad Sci U S A. 2019 May 21;116(21):10441-10446. doi: 10.1073/pnas.1902566116. Epub 2019 Apr 30.
8
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.诱导多能干细胞的低免疫原性衍生物可逃避完全免疫活性同种异体受者的免疫排斥。
Nat Biotechnol. 2019 Mar;37(3):252-258. doi: 10.1038/s41587-019-0016-3. Epub 2019 Feb 18.
9
The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.CD47 在肾缺血再灌注损伤发病机制和治疗中的作用。
Pediatr Nephrol. 2019 Dec;34(12):2479-2494. doi: 10.1007/s00467-018-4123-z. Epub 2018 Nov 3.
10
Porcine signal regulatory protein alpha binds to human CD47 to inhibit phagocytosis: Implications for human hematopoietic stem cell transplantation into severe combined immunodeficient pigs.猪信号调节蛋白 alpha 与人 CD47 结合抑制吞噬作用:对人造血干细胞移植入严重联合免疫缺陷猪的影响。
Xenotransplantation. 2019 Mar;26(2):e12466. doi: 10.1111/xen.12466. Epub 2018 Oct 12.